A first-in-human, phase I study of an oral hedgehog pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumorsLillian L. Siu,Kyriakos P. Papadopoulos,Steven R. Alberts, Sara Taylor,Amita Patnaik,Eric X. Chen,Anthony Tolcher,Blisse Vakkalaguada,Lixin Lang,Christoph Ahlers,Kelly L. Bennett, Jan M. Van TornoutMOLECULAR CANCER THERAPEUTICS（2009）引用 6|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
